Please assess the completion status of the following clinical trial:

Trial Title: Study of Pazopanib Monotherapy in Patients With Unresectable, Metastatic Neuroendocrine Tumor

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* low to intermediate grade neuroendocrine tumor not amenable to surgery or local therapy~Exclusion Criteria:~* poorly differentiated (high grade or anaplastic)/small cell, pheochromocytoma

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Pazopanib (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).